GP User Survey Feedback 2022

As the Pathology Service is accredited by United Kingdom Accreditation Service (UKAS) to ISO15189, the information provided will form a part of our compliance with UKAS standards and the results made available to them for scrutiny. The user surveys have now closed. Thank you for your help and assistance Please see the Feedback and Reponses to the surveys below :-

User Survey Feedback 2022

As the Pathology Service is accredited by United Kingdom Accreditation Service (UKAS) to ISO15189, the information provided will form a part of our compliance with UKAS standards and the results made available to them for scrutiny. The user surveys have now closed. Thank you for your help and assistance Please see the Feedback and Reponses to the surveys below :-

Pre-eclampsia screen test withdrawal

Pre-eclampsia screen test withdrawal

The Clinical Biochemistry services within North West Anglia Foundation Trust (NWAFT) have offered a Pre-Eclampsia Screen (Soluble FMS-like Tyrosine Kinase-1/Placental Growth Factor) since 2020. 

From Monday 12th December 2022 this test will no longer be available. It will no longer be available for requesting via ICE Order Comms and any requests received in the laboratory will issued with a report indicating that the request has been rejected. 

Paediatric Acute Hepatitis

Dear Colleagues,

 

Following an increase in cases of acute hepatitis of unknown origin in children, for patients <16 years old, we have updated our critical limit for urgent communication for ALT to >500U/L in primary and secondary care (effective 25/04/2022).

 

Our critical communication cut off for AST remains unchanged at >525U/L (adults and paediatrics). 

 

Pages